Exicure, Inc. (XCUR)
NASDAQ·Healthcare·Biotechnology
$2.18
+0.46%
Mkt Cap $26.07M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+450.5%
Consensus $12.00 vs current $2.18
NASDAQ·Healthcare·Biotechnology
$2.18
+0.46%
Mkt Cap $26.07M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+450.5%
Consensus $12.00 vs current $2.18